Sequential ICI plus Anti-VEGF/TKI with On-Demand TACE beyond RECIST Progression Improves Pathological Response, Resectability, and Survival in Unresectable HCC

Liver Cancer 2026 Open access

Read full text

Authors: Masatoshi Kudo

DOI: 10.1159/000551332

Cited by: 4

References: 23

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Angiogenesis and VEGF in Cancer Gastric Cancer Management and Outcomes

References 23